Bilibili Inc.
Bilibili Inc. (BLBLF) Financial Performance & Income Statement Overview
Review Bilibili Inc. (BLBLF) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Bilibili Inc. (BLBLF) Income Statement & Financial Overview
View the income breakdown for Bilibili Inc. BLBLF across both annual and quarterly reports.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $7.003B | $7.73B | $7.31B | $6.13B |
| Cost of Revenue | $4.46B | $4.95B | $4.76B | $4.29B |
| Gross Profit | $2.54B | $2.79B | $2.55B | $1.83B |
| Gross Profit Ratio | $0.36 | $0.36 | $0.35 | $0.30 |
| R&D Expenses | $841.48M | $919.32M | $906.07M | $894.70M |
| SG&A Expenses | $1.68B | $1.74B | $1.71B | $1.52B |
| Operating Expenses | $2.52B | $2.66B | $2.61B | $2.42B |
| Total Costs & Expenses | $6.99B | $7.61B | $7.37B | $6.71B |
| Interest Income | $94.17M | $110.15M | $91.28M | $100.34M |
| Interest Expense | $32.57M | $19.99M | $17.82M | $19.81M |
| Depreciation & Amortization | $494.49M | $682.60M | $682.60M | $682.60M |
| EBITDA | $33.48M | $809.04M | -$70.40M | $97.46M |
| EBITDA Ratio | $0.005 | $0.10 | -$0.010 | $0.02 |
| Operating Income | $15.008M | $126.44M | -$66.68M | -$585.13M |
| Operating Income Ratio | $0.002 | $0.02 | -$0.009 | -$0.10 |
| Other Income/Expenses (Net) | -$14.10M | -$61.04M | -$21.55M | -$29.17M |
| Income Before Tax | $911000.00 | $65.40M | -$88.22M | -$614.30M |
| Income Before Tax Ratio | $0.00 | $0.008 | -$0.01 | -$0.10 |
| Income Tax Expense | $11.59M | -$23.53M | -$8.42M | -$6.15M |
| Net Income | -$9.10M | $89.96M | -$79.52M | -$608.70M |
| Net Income Ratio | -$0.001 | $0.01 | -$0.01 | -$0.10 |
| EPS | -$0.02 | $0.22 | -$0.19 | -$1.46 |
| Diluted EPS | -$0.02 | $0.21 | -$0.19 | -$1.46 |
| Weighted Avg Shares Outstanding | $420.09M | $417.83M | $417.85M | $416.29M |
| Weighted Avg Shares Outstanding (Diluted) | $420.09M | $424.21M | $420.25M | $416.29M |
The company's financials show resilient growth, with revenue advancing from $6.13B in Q2 2024 to $7.003B in Q1 2025. Gross profit remained healthy with margins at 36% in Q1 2025 compared to 30% in Q2 2024. Operating income hit $15.008M last quarter, sustaining a consistent 0% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $33.48M. Net income dropped to -$9.10M, while earnings per share reached -$0.02. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan